Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 12;23(6):e1-9.
doi: 10.5830/CVJA-2011-069.

p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease

Affiliations

p53 negatively regulates the osteogenic differentiation of vascular smooth muscle cells in mice with chronic kidney disease

K L Li et al. Cardiovasc J Afr. .

Abstract

Aim: To investigate the osteogenic differentiation of vascular smooth muscle cells (VSMCs) in mice with chronic kidney disease (CKD) and to evaluate the effects of p53 on the osteogenic differentiation of the VSMCs.

Methods: Experimental models of CKD-associated vascular calcification generated by five-sixth (5/6) nephrectomy (Nx) and a high-phosphate (HP) diet were used in p53+/+ and p53-/- mice. Following 5/6 Nx, aortic calcification, markers of osteogenic differentiation, VSMCs and p53 protein in aortic tissues were studied.

Results: Aortic calcification was observed after eight weeks following 5/6 Nx in mice of both genotypes, and expression of the markers of osteogenic differentiation in the VSMCs was increased. These changes were continuously observed up to 12 weeks after 57/6 Nx, and particularly after 5/6 Nx + HP. Compared with p53+/+ mice, aortic calcification in p53-/- mice was more severe (p < 0.001). Expression of the markers of osteogenic differentiation was noticeably increased (p < 0.001), while expression of the marker of VSMCs had decreased (p < 0.001). Statistical analysis demonstrated that the markers of osteogenic differentiation were negatively correlated with p53, and the marker of VSMCs was positively correlated with p53 (p < 0.001).

Conclusion: p53 has the potential to negatively regulate the osteogenic differentiation of VSMCs in CKD mice.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
I: Histological appearance of the kidney in A and C: p53+/+ mice, and B and D: p53–/– mice at 12 weeks after 5/6 Nx or 5/6 Nx + HP diet. A and B: Nx mice, C and D: Nx + HP mice (HE staining, original magnification: × 200). II: Quantification of glomerular cell number, sclerosis index and tubulo-interstitial fibrosis in mice at 12 weeks after Nx or Nx + HP. Values are means ± SEM; n = 5 per group. NS = no significant difference vs p53–/– mice.
Fig. 2.
Fig. 2.
Ⅰ: Histopathological analysis of vascular calcification in the aorta at 12 weeks after Nx or Nx + HP (original magnification, × 200) with von Kossa staining. A and C: p53+/+ mice, and B and D: p53–/– mice. Ⅱ: Evaluation of the vascular calcification score in p53+/+ and p53–/– mice at 12 weeks after 5/6 Nx or 5/6 Nx + HP. Values are means ± SE; n = 5 per group. ap < 0.001 vs p53+/+ mice, bp < 0.01 vs Nx mice.
Fig. 3.
Fig. 3.
Indirect immunofluorescence staining analysis for BMP-2, RUNX2 and Osx in the aorta at 12 weeks after 5/6 Nx or 5/6 Nx + HP (original magnification, × 200). Positive staining of BMP-2, RUNX2 and Osx protein was detected in VSMCs, clumping or a green line demonstrated the expression of protein, but in p53+/+ or 5/6 Nx mice, a weaker signal was detected compared with those in p53–/– or 5/6 Nx + HP mice.
Fig. 4.
Fig. 4.
Immunohistochemistry analysis for p53, ALP and α-SMA in the aorta at 12 weeks after 5/6 Nx or 5/6 Nx + HP (original magnification, × 200). In p53–/– mice with 5/6 Nx + HP, ALP expression was high, but α-SMA was low, and no p53 was detected, while related heavy mineral deposition was also detected. On the other hand, a weak positive staining of ALP, and enhanced positive staining of p53 and α-SMA was detected in p53+/+ mice, while moderate mineral deposition could be detected. A brown colour indicated the presence of proteins and a black colour indicated mineral deposition.
Fig. 5.
Fig. 5.
Western blot analysis for p53, BMP-2 and RUNX2 in the aorta at 12 weeks after 5/6 Nx or 5/6 Nx + HP. A densitometry graph shows the expression levels of each calcification-related protein identified by Western blot analysis in the aorta. The graph indicates the relative band density when levels of GAPDH protein expression in each sample were calculated as 100%. Values are means ± SE; n = 5 per group. ap < 0.001 vs p53–/– mice, NS = no significant difference vs 5/6 Nx mice with the same genetype.
Fig. 6.
Fig. 6.
Western blot analysis for Osx, ALP and α-SMA in the aorta at 12 weeks after 5/6 Nx or 5/6 Nx + HP. A densitometry graph shows the expression levels of each calcification-related protein identified by Western blot analysis in the aorta. The graph indicates the relative band density when levels of GAPDH protein expression in each sample were calculated as 100%. Values are means ± SE; n = 5 per group. ap < 0.001 vs p53–/– mice, bp < 0.05, cp < 0.01 vs 5/6 Nx mice with the same genetype.

Similar articles

Cited by

References

    1. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85–97. - PubMed
    1. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M. et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047. - PubMed
    1. Westenfeld R, Schäfer C, Smeets R, Brandenburg VM, Floege J, Ketteler M, Jahnen-Dechent W. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant. 2007;22:1537–1546. - PubMed
    1. Collins AJ, Li S, Ma JZ, Herzog C. Cardiovascular disease in endstage renal disease patients. Am J Kidney Dis. 2001;38:S26–S29. - PubMed
    1. Chen NX, Moe SM. Vascular calcification in chronic kidney disease. Semin Nephrol. 2004;24:61–68. - PubMed

Publication types

MeSH terms